… Interferon alpha 2b (IFN) combined with cytarabine versus interferon alone in chronic
myelogenous leukemia. … leukemia by quantitative polymerase chain reaction. …

… the chronic phase of chronic myelogenous leukemia (CML Study … of CML patients treated
with interferon alpha monitored by … -α therapy by competitive polymerase chain reaction. Blood …

… Quantitative polymerase chain reaction is used to monitor … after treatment with interferon-alpha
because Brazil public … to discriminate between the competing possibilities of achieving an …

… for monitoring minimal residual disease after successful therapy… Polymerase chain reaction
involves the amplification of … well as competitive nested RT-PCR for disease monitoring.157, …

… shown that there is competition between the Ph positive and Ph negative clones, so that
the emergence of Ph negative clonal abnormalities may reflect the efficient suppression of the …

… The quantitative real-time polymerase chain reaction method (… adherence in chronic
myelogenous leukemia in the chronic … after failure of interferon-alpha treatment. Blood 1;111(3):…

… The use of real-time quantitative polymerase chain reaction (… In 1993 Cross and colleagues
introduced a competitive … of BCR-ABL are necessary to monitor the performance of the assay, …

… Baseline reverse transcriptase-polymerase chain reaction is … It acts via competitive inhibition
at the ATP-binding site of the … Given the equivalent efficacy and lower toxicity of lower dose …

… The role of modern droplet digital polymerase chain reaction (… to the treatment of TKI, then
interferon alpha (IFN-α) therapy is … to the patient allows for careful monitoring of the patient. …

… ) in chronic myelogenous leukemia (CML) patients treated … by real‑time polymerase chain
reaction technique. Results: No … of the drugs used to treat cancer such as interferon‑alpha (…